Paid Clinical Trials Nashville
Discover 1,259 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15
Sponsor:
Moderna
Location:
Code:
NCT05575492
Conditions
Cytomegalovirus
Eligibility Criteria
Sex: All
Age: 9 - 15
Healthy Volunteers: Accepted
Interventions
mRNA-1647
Placebo
Percutaneous InterventionPercutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants
Sponsor:
Nationwide Children's Hospital
Location:
Code:
NCT05547165
Conditions
Ductus Arteriosus, Patent
Eligibility Criteria
Sex: All
Age: 7 - 32
Healthy Volunteers: Not accepted
Interventions
Percutaneous Patent Ductus Arteriosus Closure (PPC)
Responsive Management Intervention
Echocardiogram, cardiac
Pembrolizumab with ChemoSplit Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer
Sponsor:
Vanderbilt-Ingram Cancer Center
Location:
Code:
NCT05501665
Conditions
Lung Non-Small Cell Carcinoma
Stage IV Lung Cancer AJCC v8
Stage III Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Carboplatin
Computed Tomography
Fludeoxyglucose F-18
Nab-paclitaxel
CPO301A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Sponsor:
Conjupro Biotherapeutics, Inc.
Location:
Code:
NCT05948865
Conditions
Cancer
Cancer, Lung
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CPO301
Gene SignaturesGene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Sponsor:
Sonya Reid
Location:
Code:
NCT05693766
Conditions
Invasive Mammary Carcinoma
Metastatic Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Capecitabine
Endocrine-therapy
MammoPrint ® and BluePrint assays
RO7656594A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Sponsor:
Genentech, Inc.
Location:
Code:
NCT05800665
Conditions
Advanced Prostate Cancer
Metastatic Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
RO7656594
Rinatabart SesutecanRinatabart Sesutecan (Rina-S) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Sponsor:
Genmab
Location:
Code:
NCT05579366
Conditions
Platinum-Resistant Ovarian Cancer
Platinum Sensitive Ovarian Cancer (PSOC)
High Grade Epithelial Ovarian Cancer
High Grade Serous Ovarian Cancer
Primary Peritoneal Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Rina-S
Carboplatin
Bevacizumab
Pembrolizumab
BemarituzumabA Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
Sponsor:
Amgen
Location:
Code:
NCT05325866
Conditions
Solid Tumors
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Bemarituzumab
Observational StudyGastrointestinal Biomarkers in Tissue and Biological Fluid Samples from Colorectal Cancer Patients
Sponsor:
Vanderbilt University Medical Center
Location:
Code:
NCT00899626
Conditions
Colorectal Cancer
Esophageal Cancer
Gastric Cancer
Pancreatic Cancer
Precancerous Condition
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted